Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation

Media formats available:

An option for lowering BP beyond prescribing an additional pill
An option for lowering BP beyond prescribing an additional pill
AHA 2023
An option for lowering BP beyond prescribing an additional pill
- Florian Rader, MD
Benefit of TTR-stabilizer starts as early as 3 months in transthyretin amyloid cardiomyopathy
Benefit of TTR-stabilizer starts as early as 3 months in transthyretin amyloid cardiomyopathy
AHA 2023
Benefit of TTR-stabilizer starts as early as 3 months in transthyretin amyloid cardiomyopathy
- Ahmad Masri, MD
Three fascinating new strategies for lipid management
Three fascinating new strategies for lipid management
AHA 2023
Three fascinating new strategies for lipid management
- Karol Watson, MD, PhD
GLP-1RA for CVD risk reduction in obesity and overweight - Clinical implications
GLP-1RA for CVD risk reduction in obesity and overweight - Clinical implications
AHA 2023
GLP-1RA for CVD risk reduction in obesity and overweight - Clinical implications
- Michael Lincoff, MD

PACE-CME